Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance

View through CrossRef
AbstractWith the extensive application of doxorubicin (DOX), DOX resistance has become one of the main obstacles to the effective treatment of breast cancer. In this paper, DOX and resveratrol (RES) were co-encapsulated in a modified PLGA nanoparticle (NPS) to overcome the DOX resistance. CLSM results indicated that DOX and RES were simultaneously delivered into the nucleus of DOX-resistant human breast cancer cells by DOX/RES-loaded NPS. Consequently, DOX/RES-loaded NPS showed significant cytotoxicity on MDA-MB-231/ADR cells and MCF-7/ADR cells. Furthermore, DOX/RES-loaded NPS could overcome DOX resistance by inhibiting the expression of drug resistance-related protein such as P-gp, MRP-1 and BCRP, and induce apoptosis through down-regulating the expression of NF-κB and BCL-2. In tumor-bearing mice, DOX/RES-loaded NPS mainly delivered DOX and RES to tumor tissue. Compared with free DOX, DOX/RES-loaded NPS significantly inhibited the DOX-resistant tumor growth in tumor-bearing mice without causing significant systemic toxicity. In a word, DOX/RES-loaded NPS could overcome the DOX resistance and had the potential in the treatment of DOX-resistant breast cancer.
Title: Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
Description:
AbstractWith the extensive application of doxorubicin (DOX), DOX resistance has become one of the main obstacles to the effective treatment of breast cancer.
In this paper, DOX and resveratrol (RES) were co-encapsulated in a modified PLGA nanoparticle (NPS) to overcome the DOX resistance.
CLSM results indicated that DOX and RES were simultaneously delivered into the nucleus of DOX-resistant human breast cancer cells by DOX/RES-loaded NPS.
Consequently, DOX/RES-loaded NPS showed significant cytotoxicity on MDA-MB-231/ADR cells and MCF-7/ADR cells.
Furthermore, DOX/RES-loaded NPS could overcome DOX resistance by inhibiting the expression of drug resistance-related protein such as P-gp, MRP-1 and BCRP, and induce apoptosis through down-regulating the expression of NF-κB and BCL-2.
In tumor-bearing mice, DOX/RES-loaded NPS mainly delivered DOX and RES to tumor tissue.
Compared with free DOX, DOX/RES-loaded NPS significantly inhibited the DOX-resistant tumor growth in tumor-bearing mice without causing significant systemic toxicity.
In a word, DOX/RES-loaded NPS could overcome the DOX resistance and had the potential in the treatment of DOX-resistant breast cancer.

Related Results

Delipidating effect of resveratrol metabolites in 3T3‐L1 adipocytes
Delipidating effect of resveratrol metabolites in 3T3‐L1 adipocytes
ScopeDue to the low bioavailability of resveratrol, determining whether its metabolites exert any beneficial effect is an interesting issue.Methods and results3T3‐L1 maturing pre‐a...
GW24-e2975 Over-expression of calpastatin aggravates in vitro and in vivo cardiotoxicity induced by doxorubicin
GW24-e2975 Over-expression of calpastatin aggravates in vitro and in vivo cardiotoxicity induced by doxorubicin
Objectives Doxorubicin often causes damage to the heart, which may present as cardiomyopathy. However, the mechanisms by which doxorubicin induces cardiotoxicity ...
TWO METHODS OF ORAL DELIVERY OF RESVERATROL: A CASE STUDY
TWO METHODS OF ORAL DELIVERY OF RESVERATROL: A CASE STUDY
Background: Resveratrol is one of the most popular nutrition supplements, especially in the older population segment, yet its safety and health benefits are not fully established. ...
Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes
Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured Hepatocytes
Steatosis is characterized primarily by excessive lipid accumulation in the form of triglycerides in the liver. Although resveratrol shows a low bioavailability, it has significant...
Abstract 1762: MALT1 is activated by doxorubicin and mediates therapy resistance in triple-negative breast cancer
Abstract 1762: MALT1 is activated by doxorubicin and mediates therapy resistance in triple-negative breast cancer
Abstract Background: Breast cancer is the most commonly diagnosed malignancy in American women. The triple-negative breast cancer (TNBC) subtype has among the worst ...

Back to Top